An FDA Regulated, Prescription-Strength Folate for Depression
-Recommended by Providers Nationwide-
ENL is a Non-Prescription, Medical Food, Developed to Provide a Safe and Effective Option for Patients Suffering from Depression.
ENL Contains Proven, Evidence-Based Ingredients to Help Manage Depression by Combining Coenzymes, Cofactors, and Omegas to Normalize and Balance Serotonin, Dopamine, and Norepinephrine (Brain Chemicals that Regulate Mood).
ENL Helps with Overall Mood, Anxiety, Irritability, Apathy, Concentration, Motivation, Energy, and Sleep.
"Vitamin intake is not the problem, it's vitamin metabolism...how well we metabolize those vitamins to the active forms needed by the brain are what can put you at risk for various illnesses and now we have a way to circumvent all of those genetic variances"
Andrew Farah, MD , Chief of Psychiatry, High Point Division of UNC Healthcare
ENL is a prescription-strength, all-natural folate containing L-Methyfolate and other important active ingredients that have been clinically shown to improve depressive symptoms in patients with Major Depressive Disorder (MDD) and who also tested positive for an MTHFR polymorphism.
ENL goes to work fast. Patients in a monotherapy study began seeing results in as little as 2 weeks and did not report any side effects greater than placebo.
ENL uses safe ingredients that are generally recognized as safe (GRAS) by the FDA. ENL is manufactured under strict requirements established by the FDA and its ingredients are gluten free, dairy free, wheat free, sugar free, egg free, and contains no artificial colorants.
% of clinical trial participants who improved on EnLyte (ENL)
% of clinical trial participants who achieved full remission on EnLyte (ENL)
AMERICAN PSYCHIATRIC ASSOCIATION
"There is consistent and growing evidence of a role for various folate forms in the prevention and treatment of depression... [Adding] Folate can also be used to enhance antidepressant efficacy (effectiveness) from the start of treatment or for patients who are already on antidepressant treatment"
Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Assessment of Evidence, Challenges, and Recommendations
Marlene Freeman MD, Maurizio Fava MD, J Lake, MH Trivedi MD, David Mischoulon MD
WHAT PROVIDERS ARE SAYING
“I just saw a young man who is a 27 year old law student. He reports depression since the age of 15 and was severely depressed with active suicidal thoughts. I did genetic testing which revealed reduced MTHFR so I started him on Enlyte (ENL). I saw him today and he has no suicidal thoughts and is more motivated. He is not tired, is more social and going to the gym. He had no anxiety with speaking up in class (his voice didn’t shake and he felt fine). He has improved focus and he wakes up feeling good. Going to bed is now easy for him and he's sleeping well. He isn't paranoid and doesn't have violent feelings towards others… AMAZING!” *
*The testimonials reflect the real-life experiences of providers who recommended our products. However, individual results may vary. Testimonials are not necessarily representative of what anyone else using our products may experience. Some testimonials may have been edited for clarity or shortened in cases where the original testimonial included additional information of no relevance to the general public.
A 22 Case Report Series on Children and Adolescents using Enlyte
"The occurrence of major depression is increasing in our pediatric population. Prior to the COVID-19 pandemic, the rate of major depression was 1% to 2% annually for patients up to age 13, with an increasing prevalence through adolescence, reaching up to 7% by age 15, and the lifetime prevalence of depression has been estimated to be as high as 25% by the end of adolescence